Chimeric antigen receptor T cell (CAR‐T cell) therapies have shown significant efficacy in
CD19+ leukemias and lymphomas. There remain many challenges and questions for …

Chimeric antigen receptor (CAR) T-cell therapy has shown promise in the treatment of
haematological cancers and is currently being investigated for solid tumours, including high …

Chimeric antigen receptor T‐cell (CART) therapy is a new and promising cancer therapy.
However, severe toxicity due to cytokine release syndrome (CRS) in CART‐treated patients …

Abstract The Federal Drug Administration approved the first Chimeric Antigen Receptor T-
cell (CAR T-cell) therapies for the treatment of several blood cancers in 2017, and efforts are …

Bispecific T-cell engaging therapies harness the immune system to elicit an effective
anticancer response. Modulating the immune activation avoiding potential adverse effects …

Cytokine storm is a life-threatening inflammatory response that is characterized by
hyperactivation of the immune system, and which can be caused by various therapies …

Chimeric antigen receptor (CAR) T-cell based immunotherapy has shown its potential in
treating blood cancers, and its application to solid tumors is currently being extensively …

Adoptive T cell based immunotherapy is gaining significant traction in cancer treatment.
Despite its limited efficacy so far in treating solid tumors compared to hematologic cancers …

Cytokine storm is a life-threatening inflammatory response characterized by hyperactivation
of the immune system. It can be caused by various therapies, auto-immune conditions, or …

Рассматривается управляемая математическая модель лечения лейкемии, в основе
которой лежит трехмерная модель хищник жертва Лотки Вольтерры. Эта модель …